Miles Nunn
Chief Tech/Sci/R&D Officer bij AKARI THERAPEUTICS, PLC
Vermogen: - $ op 31-07-2023
Actieve functies van Miles Nunn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AKARI THERAPEUTICS, PLC | Chief Tech/Sci/R&D Officer | 01-09-2015 | - |
Loopbaan van Miles Nunn
Eerdere bekende functies van Miles Nunn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Evolutec Group Plc
 Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Corporate Officer/Principal | - | - |
| Amplion Ltd. | Director/Board Member | - | - |
Volution Immuno Pharmaceuticals SA
 Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The private company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Chief Tech/Sci/R&D Officer | 01-04-2014 | - |
Opleiding van Miles Nunn
| University of Oxford | Doctorate Degree |
| University College London | Undergraduate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 5 |
| Zwitserland | 2 |
| Verenigde Staten | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AKARI THERAPEUTICS, PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Evolutec Group Plc
Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Health Technology |
Volution Immuno Pharmaceuticals SA
Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The private company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Health Technology |
| Amplion Ltd. |
- Beurs
- Insiders
- Miles Nunn
- Ervaring
